NDC 49884-151 – Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride

Bismuth Subcitrate Potassium 140 mg/1; Metronidazole 125 mg/1; Tetracycline Hydrochloride 125 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC49884-151

Product details

Brand name
Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
Generic name
Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
Labeler
Par Health USA, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA205770
Marketed since
March 7, 2023
Listing expires
December 31, 2027
Pharmacologic class
Bismuth; Nitroimidazole Antimicrobial; Tetracycline-class Antimicrobial

Active ingredients

Uses, dosage, side effects and warnings for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
49884-151-54120 CAPSULE in 1 CARTON (49884-151-54)Mar 7, 2023

Other Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride products